(Total Views: 298)
Posted On: 03/29/2022 10:46:00 AM
Post# of 97

$IMGN News Article - ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer https://marketwirenews.com/news-releases/immu...93495.html


My Twitter: WhyteStocks